PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China

Breast Cancer Research and Treatment

Volumn 129, Issue 1, 2011, Pages 195-201

  Hua, Zhang ^a   Li, Dalin ^a   Xiang, Gao ^a   Xu, Fengyan ^a   Jie, Guan ^b   Fu, Zhenkun ^a   Jie, Zhang ^a   Da, Pang ^a   Li, Dianjun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Haplotype; Polymorphism; Programmed death 1

Indexed keywords

ADENINE; CYTOSINE; GUANINE; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN P53; THYMINE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CHINA; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGRAMMED CELL DEATH 1 RECEPTOR; RISK;

EID: 79960841055     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1440-3     Document Type: Article

References (33)

1. L Chen 2004 Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity Nat Rev Immunol 4 336 347 15122199 10.1038/nri1349 1:CAS:528:DC%2BD2cXjsFChsrY%3D (Pubitemid 38649276)
2. BA Inman X Frigola H Dong ED Kwon 2007 Costimulation, coinhibition and cancer Curr Cancer Drug Targets 7 15 30 17305475 10.2174/156800907780006878 1:CAS:528:DC%2BD2sXitVOgsbc%3D (Pubitemid 46345505)
3. ME Keir MJ Butte GJ Freeman AH Sharpe 2008 PD-1 and its ligands in tolerance and immunity Annu Rev Immunol 26 677 704 18173375 10.1146/annurev. immunol.26.021607.090331 1:CAS:528:DC%2BD1cXltlWktrY%3D (Pubitemid 351600389)
4. GJ Freeman AJ Long Y Iwai K Bourque T Chernova H Nishimura LJ Fitz N Malenkovich T Okazaki MC Byrne HF Horton L Fouser L Carter V Ling MR Bowman BM Carreno M Collins CR Wood T Honjo 2000 Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J Exp Med 192 1027 1034 11015443 10.1084/jem.192.7.1027 1:CAS:528:DC%2BD3cXntFSlt7o%3D
5. Y Latchman CR Wood T Chernova D Chaudhary M Borde I Chernova Y Iwai AJ Long JA Brown R Nunes EA Greenfield K Bourque VA Boussiotis LL Carter BM Carreno N Malenkovich H Nishimura T Okazaki T Honjo AH Sharpe GJ Freeman 2001 PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 261 268 11224527 10.1038/85330 1:CAS:528:DC%2BD3MXhvVaksrc%3D (Pubitemid 33706004)
6. H Nishimura T Honjo 2001 PD-1: an inhibitory immunoreceptor involved in peripheral tolerance Trends Immunol 22 265 268 11323285 10.1016/S1471-4906(01) 01888-9 1:CAS:528:DC%2BD3MXktFahu7k%3D (Pubitemid 32667515)
7. H Dong SE Strome DR Salomao H Tamura F Hirano DB Flies PC Roche J Lu G Zhu K Tamada VA Lennon E Celis L Chen 2002 Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 793 800 12091876 1:CAS:528:DC%2BD38Xls12msLo%3D
8. C Blank TF Gajewski A Mackensen 2005 Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy Cancer Immunol Immunother 54 307 314 15599732 10.1007/s00262-004-0593-x 1:CAS:528:DC%2BD2MXhtVanuro%3D (Pubitemid 40238924)
9. Y Ohigashi M Sho Y Yamada Y Tsurui K Hamada N Ikeda T Mizuno R Yoriki H Kashizuka K Yane F Tsushima N Otsuki H Yagita M Azuma Y Nakajima 2005 Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer Clin Cancer Res 11 2947 2953 15837746 10.1158/1078-0432.CCR-04-1469 1:CAS:528:DC%2BD2MXjtlejt7k%3D (Pubitemid 40525197)
10. H Ghebeh S Mohammed A Al-Omair A Qattan C Lehe G Al-Qudaihi N Elkum M Alshabanah S Bin Amer A Tulbah D Ajarim T Al-Tweigeri S Dermime 2006 The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors Neoplasia 8 190 198 16611412 10.1593/neo.05733 1:CAS:528:DC%2BD28XovVKlurs%3D (Pubitemid 43671234)
11. RH Thompson SM Kuntz BC Leibovich H Dong CM Lohse WS Webster S Sengupta I Frank AS Parker H Zincke ML Blute TJ Sebo JC Cheville ED Kwon 2006 Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up Cancer Res 66 3381 3385 16585157 10.1158/0008-5472.CAN-05- 4303 1:CAS:528:DC%2BD28XjtVOkt7w%3D
12. Y Iwai M Ishida Y Tanaka T Okazaki T Honjo N Minato 2002 Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade Proc Natl Acad Sci USA 99 12293 12297 12218188 10.1073/pnas.192461099 1:CAS:528:DC%2BD38XntlCksL8%3D
13. C Blank J Kuball S Voelkl H Wiendl B Becker B Walter O Majdic TF Gajewski M Theobald R Andreesen A Mackensen 2006 Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro Int J Cancer 119 317 327 16482562 10.1002/ijc.21775 1:CAS:528:DC%2BD28XmsVOjtL8%3D
14. H Nishimura M Nose H Hiai N Minato T Honjo 1999 Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor Immunity 11 141 151 10485649 10.1016/S1074- 7613(00)80089-8 1:CAS:528:DyaK1MXlvVShsb8%3D (Pubitemid 29428807)
15. L Prokunina C Castillejo-Lopez F Oberg I Gunnarsson L Berg V Magnusson AJ Brookes D Tentler H Kristjansdóttir G Gröndal AI Bolstad E Svenungsson I Lundberg G Sturfelt A Jönssen L Truedsson G Lima J Alcocer-Varela R Jonsson UB Gyllensten JB Harley D Alarcón-Segovia K Steinsson ME Alarcón-Riquelme 2002 A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans Nat Genet 32 666 669 12402038 10.1038/ng1020 1:CAS:528:DC%2BD38XptVShtbg%3D (Pubitemid 35435182)
16. S Flores M Beems A Oyarzun E Carrasco F Pérez 2010 Programmed cell death 1 (PDCD1) gene polymorphisms and type 1 diabetes in Chilean children Rev Med Chil 138 543 550 20668808
17. SH Lee YA Lee DH Woo R Song EK Park MH Ryu YH Kim KS Kim SJ Hong MC Yoo HI Yang 2006 Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population Arthritis Res Ther 8 R163 17064404 10.1186/ar2071
18. R Velazquez-Cruz L Orozco F Espinosa-Rosales R Carreño-Manjarrez E Solís-Vallejo ND López-Lara IK Ruiz-López AL Rodríguez-Lozano JK Estrada-Gil G Jiménez-Sánchez V Baca 2007 Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus Eur J Hum Genet 15 336 341 17228327 10.1038/sj.ejhg.5201767 1:CAS:528:DC%2BD2sXhvF2is7o%3D
19. EK Kong L Prokunina-Olsson WH Wong CS Lau TM Chan M Alarcón- Riquelme YL Lau 2005 A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese Arthritis Rheum 52 1058 1062 15818672 10.1002/art.20966 1:CAS:528:DC%2BD2MXktFCktr0%3D (Pubitemid 40530111)
20. DF Easton KA Pooley AM Dunning PD Pharoah D Thompson DG Ballinger JP Struewing J Morrison H Field R Luben N Wareham S Ahmed CS Healey, et al. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 1087 1093 17529967 10.1038/nature05887 1:CAS:528: DC%2BD2sXmvFKmurc%3D (Pubitemid 47014426)
21. Z Fu D Li W Jiang L Wang J Zhang F Xu D Pang D Li 2010 Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province Breast Cancer Res Treat 120 195 202 19585237 10.1007/s10549-009-0462-6 1:CAS:528:DC%2BC3cXntlaksw%3D%3D
22. A Ghaderi F Yeganeh T Kalantari AR Talei AM Pezeshki M Doroudchi AS Dehaghani 2004 Cytotoxic T lymphocyte antigen-4 gene in breast cancer Breast Cancer Res Treat 86 1 7 15218356 10.1023/B:BREA.0000032918.89120.8e 1:CAS:528:DC%2BD2cXltFWms74%3D (Pubitemid 38918893)
23. J Zhang M Zhang W Jiang L Wang Z Fu D Li D Pang D Li 2009 B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population BMC Cancer 9 394 19903360 10.1186/1471-2407-9-394
24. SC Lin JH Yen JJ Tsai WC Tsai TT Ou HW Liu CJ Chen 2004 Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus Arthritis Rheum 50 770 775 15022318 10.1002/art.20040 1:CAS:528:DC%2BD2cXjtVCrs78%3D (Pubitemid 38326176)
25. KM de Vooght WW van Solinge 2009 Gene promoter analysis in molecular diagnostics: do or don't? Expert Rev Mol Diagn 9 403 405 19580424 10.1586/erm.09.28
26. J Majewski J Ott 2002 Distribution and characterization of regulatory elements in the human genome Genome Res 12 1827 1836 12466286 10.1101/gr.606402 1:CAS:528:DC%2BD38XpsVOqtbo%3D (Pubitemid 35469931)
27. E Gazave T Marques-Bonet O Fernando B Charlesworth A Navarro 2007 Patterns and rates of intron divergence between humans and chimpanzees Genome Biol 8 R21 17309804 10.1186/gb-2007-8-2-r21 (Pubitemid 351851035)
28. L Balvay D Libri MY Fiszman 1993 Pre-mRNA secondary structure and the regulation of splicing Bioessays 15 165 169 8489523 10.1002/bies.950150304 1:CAS:528:DyaK3sXmtF2ls7g%3D
29. M Braddock M Muckenthaler MR White AM Thorburn J Sommerville AJ Kingsman SM Kingsman 1994 Intron-less RNA injected into the nucleus of Xenopus oocytes accesses a regulated translation control pathway Nucleic Acids Res 22 5255 5264 7816614 10.1093/nar/22.24.5255 1:CAS:528:DyaK2MXivFKmurs%3D
30. D Baralle M Baralle 2002 Splicing in action: assessing disease causing sequence changes J Med Genet 42 737 748 10.1136/jmg.2004.029538
31. A Linjawi M Kontogiannea F Halwani M Edwardes S Meterissian 2004 Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer J Am Coll Surg 198 83 90 14698315 10.1016/j.jamcollsurg.2003.08.008 (Pubitemid 38201092)
32. EA Rakha ME El-Sayed AR Green EC Paish DG Powe J Gee RI Nicholson AH Lee JF Robertson IO Ellis 2007 Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype J Clin Oncol 25 4772 4778 17876012 10.1200/JCO.2007.12.2747 (Pubitemid 350086480)
33. I Soerjomataram MW Louwman JG Ribot JA Roukema JW Coebergh 2008 An overview of prognostic factors for long-term survivors of breast cancer Breast Cancer Res Treat 107 309 330 17377838 10.1007/s10549-007-9556-1 1:CAS:528:DC%2BD1cXht1Sgtrw%3D (Pubitemid 351172108)